Concepedia

Supernus Pharmaceuticals (United States)

SP

Statistics

Publications

174

Citations

10.4K

Authors

23

Location

Rockville, United States

Supernus Pharmaceuticals (United States) is a company institution in Rockville, United States known for pharmacology, medicine, and psychopharmacology.

HomepageROR

Top concepts

Publications

174

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

Michael Millward, Timothy Price, Amanda Townsend et al. · Investigational New Drugs · 2011 · 149 citations

, , +14

<p>New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties</p>

Chung‐Ping Yu, Jennie García‐Olivares, Shawn Candler et al. · Journal of Experimental Pharmacology · 2020 · 89 citations · Full text

, , +15

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Azmi Nasser, Tesfaye Liranso, Toyin Adewole et al. · Clinical Therapeutics · 2020 · 83 citations · Full text

, , +17

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Michael Millward, Paul N. Mainwaring, Alain C. Mita et al. · Investigational New Drugs · 2011 · 74 citations

, , +5

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD

Janet Johnson, Tesfaye Liranso, Keith E. Saylor et al. · Journal of Attention Disorders · 2019 · 61 citations · Full text

, , +17

1–5 of 174

Authors

23

  1. SS
    Stefan Schwabe

    Supernus Pharmaceuticals (United States), United States

    58 publications · 1.9K citations

    21

    h-index

  2. AN
    Azmi Nasser

    Supernus Pharmaceuticals (United States), United States

    46 publications · 972 citations

    20

    h-index

  3. GD
    Gregory D. Busse

    Supernus Pharmaceuticals (United States), United States

    41 publications · 651 citations

    17

    h-index

  4. AR
    Alisa R. Kosheleff

    Supernus Pharmaceuticals (United States), United States

    21 publications · 504 citations

    13

    h-index

  5. ZM
    Zare Melyan

    Supernus Pharmaceuticals (United States), United States

    19 publications · 885 citations

    13

    h-index

1–5 of 23